| Literature DB >> 35354243 |
Sunki Kim1, Hye-Ja Park1, Dong-Ho Yang2.
Abstract
BACKGROUND: Hemodialysis patients with chronic kidney disease exhibit impaired exercise tolerance and functional decline. Despite the life-saving benefits of adequate dialysis, those declines translate into frailty and deteriorating quality of life (QoL). This study evaluated the effects of an intradialytic aerobic exercise program on frailty, dialysis adequacy, and QoL among hemodialysis patients.Entities:
Keywords: Exercise; Frailty; Quality of life; Renal dialysis
Year: 2022 PMID: 35354243 PMCID: PMC9346393 DOI: 10.23876/j.krcp.21.284
Source DB: PubMed Journal: Kidney Res Clin Pract ISSN: 2211-9132
Figure 1.Consolidated standards for reporting trials flow diagram.
Homogeneity test for demographic, dialytic, and clinical characteristics (n = 39)
| Characteristic | Exercise group | Control group | p-value | |
|---|---|---|---|---|
| Demographic characteristic | ||||
| No. of patients | 18 | 21 | ||
| Age (yr) | 57.61 ± 13.69 | 56.76 ± 12.32 | 0.20 | 0.84 |
| Sex | ||||
| Male | 10 (55.6) | 10 (47.6) | 0.24 | 0.62 |
| Female | 8 (44.4) | 11 (52.4) | ||
| Spouse | ||||
| Yes | 17 (94.4) | 18 (85.7) | 0.80 | 0.61[ |
| No | 1 (5.6) | 3 (14.3) | ||
| Educational level | ||||
| ≤High school | 10 (55.6) | 16 (76.2) | 1.86 | 0.17 |
| ≥College | 8 (44.4) | 5 (23.8) | ||
| Job | ||||
| Full time | 3 (16.7) | 3 (14.3) | 1.42 | 0.49 |
| Part time | 3 (16.7) | 7 (33.3) | ||
| None | 12 (66.7) | 11 (52.4) | ||
| Religion | ||||
| Yes | 14 (77.8) | 12 (57.1) | 1.86 | 0.31[ |
| No | 4 (22.2) | 9 (42.9) | ||
| Health insurance | ||||
| National | 15 (83.3) | 16 (76.2) | 0.30 | 0.70[ |
| Medicaid | 3 (16.7) | 5 (23.8) | ||
| Monthly income ($) | ||||
| <2,000 | 12 (66.7) | 18 (85.7) | 1.98 | 0.26[ |
| ≥2,000 | 6 (33.3) | 3 (14.3) | ||
| Dialysis-related characteristic | ||||
| Hemodialysis vintage (yr) | 2.38 ± 2.72 | 5.74 ± 3.99 | –3.10 | 0.004 |
| Dialysis duration/session (min) | 223.61 ± 17.81 | 228.10 ± 19.14 | 0.75 | 0.46 |
| Blood flow rate (mL/min) | 281.67 ± 23.58 | 276.19 ± 24.39 | 0.71 | 0.48 |
| Dialysate flow rate (mL/min) | 516.67 ± 70.71 | 571.43 ± 130.93 | 1.67 | 0.11 |
| Dialyzer efficacy | ||||
| High | 12 (66.7) | 17 (81.0) | 2.26 | 0.32[ |
| Medium | 5 (27.8) | 2 (9.5) | ||
| Low | 1 (5.6) | 2 (9.5) | ||
| Fistula type | ||||
| Arteriovenous fistula | 16 (88.9) | 16 (76.2) | ||
| Arteriovenous graft | 2 (11.1) | 5 (23.8) | 1.06 | 0.42[ |
| Clinical characteristic | ||||
| Hemoglobin (g/dL) | 10.70 ± 1.18 | 10.25 ± 1.04 | –1.27 | 0.21 |
| Albumin (g/dL) | 3.87 ± 0.18 | 3.77 ± 0.49 | –0.92 | 0.37 |
| Calcium (mg/dL) | 8.65 ± 0.65 | 8.77 ± 0.67 | –0.58 | 0.57 |
| Phosphorus (mg/dL) | 5.04 ± 1.32 | 4.81 ± 1.50 | 0.48 | 0.62 |
| Potassium (mEq/L) | 5.10 ± 0.71 | 4.69 ± 0.68 | 1.80 | 0.08 |
| Creatinine (mg/dL) | 10.09 ± 2.44 | 10.38 ± 2.21 | –0.38 | 0.71 |
| Urea reduction ratio (%) | 74.78 ± 3.83 | 74.98 ± 4.00 | 0.16 | 0.88 |
| Cause of renal failure | ||||
| Diabetes | 7 (38.9) | 11 (52.4) | 0.82 | 0.70[ |
| Hypertension | 7 (38.9) | 6 (28.6) | ||
| Others | 4 (22.2) | 4 (15.1) | ||
| Charlson comorbidity index | 5.33 ± 2.35 | 5.14 ± 2.26 | 0.26 | 0.80 |
| Dry body weight (kg) | 58.95 ± 10.30 | 56.57 ± 9.95 | 0.73 | 0.47 |
Data are expressed as number only, mean ± standard deviation, or numer (%).
Fisher exact test.
Changes in the incidence of frailty and body composition parameters (n = 39)
| Variable | Baseline | In 12 wk | ||||||
|---|---|---|---|---|---|---|---|---|
| Exercise group (n = 18) | Control group (n = 21) | p-value | Exercise group (n = 18) | Control group (n = 21) | p-value | |||
| Frailty (score) | ||||||||
| Not frail, 0-2 | 10 (55.6) | 9 (42.9) | 0.63 | 0.53 | 18 (100) | 7 (33.3) | 18.72 | <0.001[ |
| Frail, 3-5 | 8 (44.4) | 12 (57.1) | 0 (0) | 14 (66.7) | ||||
| Frailty phenotype | ||||||||
| Gait speed (m/sec) | ||||||||
| Not frail, ≥0.8 | 12 (66.7) | 11 (52.4) | 0.82 | 0.52 | 17 (94.4) | 7 (33.3) | 15.29 | <0.001[ |
| Frail, <0.8 | 6 (33.3) | 10 (47.6) | 1 (5.6) | 14 (66.7) | ||||
| Grip strength (kg) | ||||||||
| Not frail, M: ≥30 and F: ≥20 | 6 (33.3) | 12 (57.1) | 2.21 | 0.20 | 10 (55.6) | 7 (33.3) | 1.95 | 0.21 |
| Frail, M: <30 and F: <20 | 12 (66.7) | 9 (42.9) | 8 (44.4) | 14 (66.7) | ||||
| Physical activity | ||||||||
| Not frail | 10 (55.6) | 7 (33.3) | 1.95 | 0.21 | 18 (100) | 7 (33.3) | 18.72 | <0.001[ |
| Frail | 8 (44.4) | 14 (66.7) | 0 (0) | 14 (66.7) | ||||
| Exhaustion (vitality, score) | ||||||||
| Not frail, ≥55 | 6 (33.3) | 5 (23.8) | 0.43 | 0.72[ | 11 (61.1) | 2 (9.5) | 11.61 | 0.002[ |
| Frail, <55 | 12 (66.7) | 16 (76.2) | 7 (38.9) | 19 (90.5) | ||||
| Weight loss, BMI (kg/m2) | ||||||||
| Not frail, >18.5 | 16 (88.9) | 17 (81.0) | 0.47 | 0.67[ | 17 (94.4) | 17 (81.0) | 1.58 | 0.35[ |
| Frail, ≤18.5 | 2 (11.1) | 4 (19.0) | 1 (5.6) | 4 (19.0) | ||||
| SPPB (score) | ||||||||
| Not frail, 10–12 | 14 (77.8) | 14 (66.7) | 0.59 | 0.497[ | 18 (100) | 12 (57.1) | 10.03 | 0.002[ |
| Frail, <10 | 4 (22.2) | 7 (33.3) | 0 (0) | 9 (41.9) | ||||
| Skeletal muscle mass (kg) | 25.46 ± 4.80 | 24.32 ± 4.16 | 0.15 | 0.71 | 25.47 ± 4.85 | 23.17 ± 4.71 | 0.79 | 0.37[ |
| Body fat (%) | 21.17 ± 7.85 | 22.21 ± 9.99 | 0.03 | 0.86 | 21.82 ± 7.84 | 24.11 ± 9.23 | 0.43 | 0.52[ |
| Lower leg muscles (kg) | 15.42 ± 3.70 | 14.16 ± 3.51 | 1.23 | 0.27 | 13.79 ± 3.10 | 12.51 ± 2.59 | 0.80 | 0.38[ |
Data are expressed as number (%) or mean ± standard deviation.
BMI, body mass index; F, female; M, male; SPPB, short physical performance battery.
Fisher exact test,
analysis of covariance adjusted for dialysis vintage.
Within- and between-group interaction effects on frailty, dialysis adequacy, and quality of life (n = 39)
| Variable | Time (wk) | Exercise group (n = 18) | Control group (n = 21) | F | p-value | Repeated measures of ANCOVA | |||
|---|---|---|---|---|---|---|---|---|---|
| F | p-value | η₂ (f) | |||||||
| Frailty (score)[ | Baseline | 2.22 ± 1.22 | 2.52 ± 0.87 | 0.35 | 0.56 | Time | 1.80 | 0.17[ | 0.048 |
| 4th | 1.33 ± 1.14[ | 2.95 ± 1.02 | 17.52 | <0.001 | Group | 18.55 | <0.001 | 0.340 | |
| 8th | 1.11 ± 0.90[ | 3.05 ± 1.02 | 26.47 | <0.001 | T*G | 21.74 | <0.001[ | 0.376 (0.78) | |
| 12th | 0.94 ± 0.93[ | 3.10 ± 1.04 | 34.71 | <0.001 | |||||
| Gait speed (m/sec) | Baseline | 0.89 ± 0.22 | 0.83 ± 0.24 | 0.21 | 0.65 | Time | 8.18 | 0.003d | 0.185 |
| 4th | 1.14 ± 0.30[ | 0.76 ± 0.22 | 11.88 | 0.001 | Group | 12.64 | 0.001 | 0.260 | |
| 8th | 1.18 ± 0.31[ | 0.72 ± 0.19 | 20.23 | <0.001 | T*G | 32.2 | <0.001d | 0.464 (0.93) | |
| 12th | 1.21 ± 0.31[ | 0.71 ± 0.19 | 24.26 | <0.001 | |||||
| Grip strength (kg) | Baseline | 23.58 ± 9.79 | 26.10 ± 8.83 | 1.27 | 0.27 | Time | 1.92 | 0.15d | 0.051 |
| 4th | 24.00 ± 9.16 | 21.13 ± 9.51 | 0.18 | 0.68 | Group | 0.05 | 0.83 | 0.001 | |
| 8th | 25.28 ± 8.45 | 22.40 ± 9.78 | 0.52 | 0.48 | T*G | 9.73 | <0.001[ | 0.213 (0.52) | |
| 12th | 25.61 ± 8.88 | 22.07 ± 8.41 | 0.75 | 0.39 | |||||
| Exhaustion (vitality in SF-36, score) | Baseline | 48.46 ± 12.80 | 46.24 ± 10.79 | 1.27 | 0.27 | Time | 1.17 | 0.33 | 0.031 |
| 4th | 53.16 ± 12.06 | 44.11 ± 9.78 | 7.60 | 0.009 | Group | 9.96 | 0.003 | 0.217 | |
| 8th | 53.66 ± 8.99 | 41.68 ± 8.34 | 15.08 | <0.001 | T*G | 2.27 | 0.09 | 0.059 (0.25) | |
| 12th | 53.82 ± 10.06 | 43.26 ± 6.80 | 12.38 | 0.001 | |||||
| Weight loss (BMI, kg/m2) | Baseline | 21.55 ± 2.31 | 21.68 ± 3.06 | 0.03 | 0.88 | Time | 3.35 | 0.05d | 0.085 |
| 4th | 21.53 ± 2.16 | 21.68 ± 3.02 | 0.03 | 0.86 | Group | 0.03 | 0.88 | 0.001 | |
| 8th | 21.53 ± 2.01 | 21.64 ± 2.77 | 0.04 | 0.84 | T*G | 1.67 | 0.20[ | 0.044 (0.21) | |
| 12th | 21.58 ± 1.98 | 21.79 ± 3.01 | 0.24 | 0.63 | |||||
| SPPB (score)[ | Baseline | 10.67 ± 1.61 | 10.10 ± 2.02 | 0.07 | 0.79 | Time | 4.31 | 0.03[ | 0.009 |
| 4th | 11.56 ± 0.98[ | 9.52 ± 2.06 | 8.73 | 0.005 | Group | 8.73 | 0.006 | 0.142 | |
| 8th | 11.72 ± 0.67[ | 9.86 ± 2.20 | 6.96 | 0.01 | T*G | 28.81 | <0.001[ | 0.168 (0.45) | |
| 12th | 11.83 ± 0.51[ | 9.76 ± 2.28 | 9.89 | 0.003 | |||||
| Kt/V urea | Baseline | 1.64 ± 0.19 | 1.67 ± 0.19 | 0.14 | 0.71 | Time | 0.46 | 0.67[ | 0.013 |
| 4th | 1.68 ± 0.24 | 1.71 ± 0.24 | 0.05 | 0.82 | Group | 0.29 | 0.59 | 0.008 | |
| 8th | 1.70 ± 0.23 | 1.71 ± 0.28 | 0.14 | 0.71 | T*G | 2.85 | 0.05[ | 0.073 (0.28) | |
| 12th | 1.76 ± 0.30 | 1.64 ± 0.18 | 2.40 | 0.13 | |||||
| Physical component summary | Baseline | 45.51 ± 6.48 | 44.50 ± 8.76 | 1.30 | 0.26 | Time | 5.59 | 0.003[ | 0.134 |
| 4th | 49.41 ± 4.94 | 43.81 ± 7.38 | 8.35 | 0.007 | Group | 8.52 | 0.006 | 0.191 | |
| 8th | 50.31 ± 4.50 | 44.76 ± 6.88 | 7.41 | 0.01 | T*G | 1.98 | 0.13[ | 0.052 (0.23) | |
| 12th | 51.80 ± 4.51 | 42.79 ± 8.38 | 10.95 | 0.002 | |||||
| Mental component summary | Baseline | 50.35 ± 11.04 | 49.81 ± 9.17 | 0.12 | 0.73 | Time | 0.90 | 0.97 | 0.003 |
| 4th | 53.98 ± 7.83[ | 45.22 ± 8.64 | 9.41 | 0.004 | Group | 5.11 | 0.03 | 0.124 | |
| 8th | 53.24 ± 7.28[ | 44.95 ± 8.65 | 7.66 | 0.009 | T*G | 3.04 | 0.03 | 0.078 (0.29) | |
| 12th | 53.23 ± 8.60 | 48.95 ± 8.14 | 2.92 | 0.10 | |||||
Data are expressed as mean ± standard deviation.
BMI, body mass index; Kt/V, K = dialyzer’s capacity to clear urea at the blood flow rate, t = treatment time, V = distribution volume of urea; SF-36, Short Form-36 tool; SPPB, short physical performance battery; T*G, time*group.
F is effect size calculated using the analysis of covariance (ANCOVA) model adjusted for dialysis vintage in G*Power (small = 0.10, medium = 0.25, large = 0.40); F-score calculated using ANCOVA adjusted by dialysis vintage (exercise group vs. control group).
Score range:
0–5,
0–12.
Statistically significant based on Bonferroni correction (p < 0.013);
Greenhouse-Geisser correction according to Mauchly’s sphericity test (p < 0.05).
Differencesa in frailty, dialysis adequacy, and QoL according to the intention-to-treat and per-protocol analyses
| Variable | Intention-to-treat analysis (n = 42) | Per-protocol analysis (n = 39) | ||||||
|---|---|---|---|---|---|---|---|---|
| Exercise group (n = 21) | Control group (n = 21) | z[ | p-value | Exercise group (n = 18) | Control group (n = 21) | z[ | p-value | |
| Frailty score | –1.26 ± 0.96 | 0.57 ± 0.81 | –5.08 | <0.001 | –1.28 ± 1.02 | 0.57 ± 0.81 | –4.84 | <0.001 |
| Slowness (gait speed, m/sec) | 0.27 ± 0.22 | –0.11 ± 0.15 | –4.77 | <0.001 | 0.31 ± 0.19 | –0.11 ± 0.15 | –5.21 | <0.001 |
| Weakness (grip strength, kg) | 1.58 ± 3.94 | –4.02 ± 4.52 | –4.03 | <0.001 | 2.03 ± 3.79 | –4.02 ± 4.52 | –4.05 | <0.001 |
| Exhaustion (vitality, score) | 4.57 ± 7.74 | –2.98 ± 9.91 | –2.30 | 0.02 | 5.36 ± 8.09 | –2.98 ±9.91 | –2.42 | 0.02 |
| Weight loss (BMI, kg/m2) | 0.18 ± 1.20 | 0.48 ± 1.79 | –0.57 | 0.57 | 0.03 ± 1.07 | 0.48 ± 1.79 | 0.42 | 0.69 |
| SPPB (0–12, score) | 0.88 ± 1.43 | –0.33 ± 1.68 | –2.06 | 0.04 | 1.17 ± 1.29 | –0.33 ± 1.68 | –2.67 | 0.01 |
| Dialysis adequacy (Kt/V urea) | 0.13 ± 0.22 | –0.03 ± 0.13 | –2.48 | 0.01 | 0.12 ± 0.21 | –0.03 ± 0.13 | –2.48 | 0.01 |
| QoL | ||||||||
| PCS | 5.69 ± 5.58 | –1.72 ± 9.04 | –2.79 | 0.005 | 6.29 ± 5.62 | –1.72 ± 9.04 | –2.86 | 0.003 |
| MCS | 2.49 ± 7.28 | –0.86 ± 9.41 | –1.59 | 0.11 | 2.88 ± 7.79 | –0.86 ± 9.41 | –1.54 | 0.13 |
Data are expressed as mean ± standard deviation.
BMI, body mass index; Kt/V, K = dialyzer’s capacity to clear urea at the blood flow rate, t = treatment time, V = distribution volume of urea; SPPB, short physical performance battery; MCS, mental component summary; PCS, physical component summary; QoL, quality of life.
Value at the 12th week – value at baseline.
z-score calculated using the Mann-Whitney U test.